NASDAQ: TVTX · Health Care / Biotechnology: Pharmaceutical Preparations

Travere Therapeutics Inc.

How Travere Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$4.8B

Price

$50.57

P/E

-109.6

EPS (TTM)

$-0.46

1-year return

68.7%

Dividend yield

0.0%

52-week range

$34.73–$58.88

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources